UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Challenges of antibacterial discovery revisited

Annals of the New York Academy of Sciences, 2010-12, Vol.1213 (1), p.5-19

2010

Volltextzugriff (PDF)

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Volltextzugriff (PDF)

Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies

Frontiers in immunology, 2021-07, Vol.12, p.705360-705360

2021

Volltextzugriff (PDF)

Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.289-298

2015

Volltextzugriff (PDF)

A rapid microtiter plate assay for measuring the effect of compounds on Staphylococcus aureus membrane potential

Journal of microbiological methods, 2010-11, Vol.83 (2), p.254-256

2010

Volltextzugriff (PDF)

In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.729-734

2016

Volltextzugriff (PDF)

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.670-677

2016

Volltextzugriff (PDF)

Efficacy of Human Exposures of Gepotidacin (GSK2140944) against Escherichia coli in a Rat Pyelonephritis Model

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.180-189

2016

Volltextzugriff (PDF)

1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S569-S569

2019

Volltextzugriff (PDF)

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Journal of visualized experiments, 2017-01 (119)

2017

Volltextzugriff (PDF)

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Journal of visualized experiments, 2017-01 (119)

2017

Volltextzugriff (PDF)

248S-649266, a Novel Siderophore Cephalosporin: Efficacy against Klebsiella pneumoniae producing NDM-1 or KPC in rat lung infection model with recreated humanized exposure profile of 2 gram dose with 1 hour and 3 hours infusion

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S106-S107

2014

Volltextzugriff (PDF)

In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA

Journal of antimicrobial chemotherapy, 2000-04, Vol.45 (suppl-3), p.13-13

2000

Volltextzugriff (PDF)

In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens

Journal of antimicrobial chemotherapy, 2000-04, Vol.45 (suppl-3), p.23-23

2000

Volltextzugriff (PDF)

Information from your family doctor: Questions and answers about TB

American family physician, 2000-05, Vol.61 (9), p.2681

2000

Volltextzugriff (PDF)

Identification and management of tuberculosis

American family physician, 2000-05, Vol.61 (9), p.2667-2678

2000

Volltextzugriff (PDF)

Low- versus high-pressure irrigation techniques in Staphylococcus aureus-inoculated wounds

The American journal of emergency medicine, 1999-03, Vol.17 (2), p.121-124

1999

Volltextzugriff (PDF)

Structure and antimicrobial activity of new bile acid-based gemini surfactants

Perkin 2 : an international journal of physical organic chemistry, 2002-06 (7), p.1302-1306

2002

Volltextzugriff (PDF)

A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolates

Diagnostic microbiology and infectious disease, 1995-04, Vol.21 (4), p.223-225

1995

Volltextzugriff (PDF)

Pharmacological properties of dynorphin A -(2 -17) and structurally related novel peptides

Rittenhouse, Stephen F

2001

Volltextzugriff (PDF)

Nanomolar Inhibitors of Staphylococcus a ureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens

Journal of medicinal chemistry, 2002-05, Vol.45 (10), p.1959-1962

2002

Volltextzugriff (PDF)

The evolution of antimicrobial susceptibility testing methods

Advances in experimental medicine and biology, 1994, Vol.349, p.3

1994

Volltextzugriff (PDF)

Conformational Perturbation of the Envelope Glycoprotein gp120 of Human Immunodeficiency Virus Type 1 by Soluble CD4 and the Lectin Succinyl Con A

Virology (New York, N.Y.), 1993-06, Vol.194 (2), p.833-837

1993

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

ThemaAntibiotics. Antiinfectious Agents. Antiparasitic Agents

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(126)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Challenges of antibacterial discovery revisited

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics

Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies

Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections

A rapid microtiter plate assay for measuring the effect of compounds on Staphylococcus aureus membrane potential

In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Efficacy of Human Exposures of Gepotidacin (GSK2140944) against Escherichia coli in a Rat Pyelonephritis Model

Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats

Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection

1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

248S-649266, a Novel Siderophore Cephalosporin: Efficacy against Klebsiella pneumoniae producing NDM-1 or KPC in rat lung infection model with recreated humanized exposure profile of 2 gram dose with 1 hour and 3 hours infusion

In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA

In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens

Information from your family doctor: Questions and answers about TB

Identification and management of tuberculosis

Low- versus high-pressure irrigation techniques in Staphylococcus aureus-inoculated wounds

Structure and antimicrobial activity of new bile acid-based gemini surfactants

A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolates

Pharmacological properties of dynorphin A -(2 -17) and structurally related novel peptides

Nanomolar Inhibitors of Staphylococcus a ureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens

The evolution of antimicrobial susceptibility testing methods

Conformational Perturbation of the Envelope Glycoprotein gp120 of Human Immunodeficiency Virus Type 1 by Soluble CD4 and the Lectin Succinyl Con A

Aktive Filter

Suchergebnisse filtern